Special Lecture

• Tony Green (Cambridge, UK)

Session I – Heterogeneity of malignancies & metastasis

• Wolfram Klapper (Kiel, DE)

• Ruud Delwel (Rotterdam, NL)
• Marc S. Raab (Heidelberg, DE)
• Jan-Henning Klusmann, Hannover (DE)

Session II: Stem cells in homeostasis and disease

• Carol Stocking (Hamburg, DE)
• Peter Cockerill (Birmingham, UK)
• Dominik Beck, Sydney (AU)
• Martin Zörnig, Frankfurt (DE)
• Claudia Waskow (Dresden, DE)
• Tatsuya Morishima, Hannover (DE) + Kyoto (JP)
• Stefan Horn, Hamburg (DE)

Session III: Targeted therapies – what is the right cell, what is the best molecule?

• Hubert Serve (Frankfurt am Main, DE)
• Duohui Jing, Sydney (AU)
• Markus Müschen (San Francisco, US)
• Constanze Bonifer (Birmingham, GB)
• Michael Heuser (Hannover, DE)

Session IV: Adoptive Immunotherapy

• Hinrich Abken (Cologne, DE)
• Michael Hudecek (Würzburg, DE)
• Per Thor Straten (Herlev, DK)
• Stephan Grupp (Philadelphia, US)
  Fred Falkenburg (Leiden, NL)
• Hans Stauss (London, UK)

• Belinda Berdien, Hamburg (DE)

• Thomas Brabletz – German Cancer Aid, Erlangen (DE)

Session V: Gene Therapy: Oncolytic viruses on their way to the clinics

• Christian Buchholz (Langen, DE)
• Dorothee von Laer (Innsbruck, AT)
• Caroline Breitbach (San Francisco, US)
• Guy Ungerechts (Heidelberg, DE)

Session VI: Epigenetics and cell ageing

• Phil Koeffler (Los Angeles, US)
• Thomas Brabletz (Erlangen, DE)
• Hartmut Geiger, Ulm (DE)
• José Martin-Sobero (Barcelona, ES)
• Daniel G. Tenen (Singapore, SG)
• Tobias Berg, Frankfurt (DE